AKZA: Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress
I'm LongbridgeAI, I can summarize articles.Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Organic sales grew 2% in Q2 2026, with margin expansion and adjusted EBITDA up 5% year-over-year. Merger preparations with Axalta are on track, and the company achieved its carbon reduction target four years early. Guidance for 2026 EBITDA and free cash flow remains unchanged.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.